Cargando…

Risk Factor Control Five Years after Coronary Bypass Grafting

The prevalence of three major coronary risk factors, hyperlipidaemia, hypertension and cigarette smoking, and the change in lipid fractions were assessed five years after coronary bypass surgery and compared to pre-operation in 353 consecutive patients undergoing elective first time surgery at a sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Skinner, J S, Farrer, M, Albers, C J, Adams, P C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of Physicians of London 1996
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401540/
https://www.ncbi.nlm.nih.gov/pubmed/8709060
_version_ 1783231072305152000
author Skinner, J S
Farrer, M
Albers, C J
Adams, P C
author_facet Skinner, J S
Farrer, M
Albers, C J
Adams, P C
author_sort Skinner, J S
collection PubMed
description The prevalence of three major coronary risk factors, hyperlipidaemia, hypertension and cigarette smoking, and the change in lipid fractions were assessed five years after coronary bypass surgery and compared to pre-operation in 353 consecutive patients undergoing elective first time surgery at a single centre. Five years after surgery 309 patients were alive without further cardiac surgery, questionnaire follow-up was available in 291 (94%). Lipid profile measurements were made in 255 (83%) of these five-year survivors and 100 (34%) had a history of hypertension. Five years after surgery, 146 (50%) of the 291 patients thought they had high cholesterol, of whom 92 (63%) were following a diet, 36 (25%) were also taking lipid-lowering drugs and 18 (12%) were taking no measures; 141 (48%) of them did not think they had high cholesterol, and four (2%) did not know. There had been a favourable change in all lipid fractions compared with pre-operation, including total serum cholesterol, particularly in patients taking lipid-lowering drugs. However, total serum cholesterol was above 5.2 mmol/l in 203 (80%) patients and low-density lipoprotein (LDL) cholesterol was above 3.4 mmol/l in 180 (71%). Only 30% of patients taking lipid-lowering drugs had an LDL cholesterol of 3.4 mmol/l or less. Blood pressure was recorded in 257 (83%) of the 309 five-year survivors: 82 (28%) were taking antihypertensive medication; 32 (12%) and 87 (34%) patients had a diastolic blood pressure above 95 mmHg and 90 mmHg, respectively, and 49 (19%) had a systolic blood pressure above 160 mmHg. There were 22 (9%) regular cigarette smokers. Corroboration of non-smoking with exhaled carbon monoxide measurements confirmed an accurate history of non-smoking in nearly all patients.
format Online
Article
Text
id pubmed-5401540
institution National Center for Biotechnology Information
language English
publishDate 1996
publisher Royal College of Physicians of London
record_format MEDLINE/PubMed
spelling pubmed-54015402019-01-22 Risk Factor Control Five Years after Coronary Bypass Grafting Skinner, J S Farrer, M Albers, C J Adams, P C J R Coll Physicians Lond Original Papers The prevalence of three major coronary risk factors, hyperlipidaemia, hypertension and cigarette smoking, and the change in lipid fractions were assessed five years after coronary bypass surgery and compared to pre-operation in 353 consecutive patients undergoing elective first time surgery at a single centre. Five years after surgery 309 patients were alive without further cardiac surgery, questionnaire follow-up was available in 291 (94%). Lipid profile measurements were made in 255 (83%) of these five-year survivors and 100 (34%) had a history of hypertension. Five years after surgery, 146 (50%) of the 291 patients thought they had high cholesterol, of whom 92 (63%) were following a diet, 36 (25%) were also taking lipid-lowering drugs and 18 (12%) were taking no measures; 141 (48%) of them did not think they had high cholesterol, and four (2%) did not know. There had been a favourable change in all lipid fractions compared with pre-operation, including total serum cholesterol, particularly in patients taking lipid-lowering drugs. However, total serum cholesterol was above 5.2 mmol/l in 203 (80%) patients and low-density lipoprotein (LDL) cholesterol was above 3.4 mmol/l in 180 (71%). Only 30% of patients taking lipid-lowering drugs had an LDL cholesterol of 3.4 mmol/l or less. Blood pressure was recorded in 257 (83%) of the 309 five-year survivors: 82 (28%) were taking antihypertensive medication; 32 (12%) and 87 (34%) patients had a diastolic blood pressure above 95 mmHg and 90 mmHg, respectively, and 49 (19%) had a systolic blood pressure above 160 mmHg. There were 22 (9%) regular cigarette smokers. Corroboration of non-smoking with exhaled carbon monoxide measurements confirmed an accurate history of non-smoking in nearly all patients. Royal College of Physicians of London 1996 /pmc/articles/PMC5401540/ /pubmed/8709060 Text en © Journal of the Royal College of Physicians of London 1996 http://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) , which permits non-commercial use and redistribution provided that the original author and source are credited.
spellingShingle Original Papers
Skinner, J S
Farrer, M
Albers, C J
Adams, P C
Risk Factor Control Five Years after Coronary Bypass Grafting
title Risk Factor Control Five Years after Coronary Bypass Grafting
title_full Risk Factor Control Five Years after Coronary Bypass Grafting
title_fullStr Risk Factor Control Five Years after Coronary Bypass Grafting
title_full_unstemmed Risk Factor Control Five Years after Coronary Bypass Grafting
title_short Risk Factor Control Five Years after Coronary Bypass Grafting
title_sort risk factor control five years after coronary bypass grafting
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401540/
https://www.ncbi.nlm.nih.gov/pubmed/8709060
work_keys_str_mv AT skinnerjs riskfactorcontrolfiveyearsaftercoronarybypassgrafting
AT farrerm riskfactorcontrolfiveyearsaftercoronarybypassgrafting
AT alberscj riskfactorcontrolfiveyearsaftercoronarybypassgrafting
AT adamspc riskfactorcontrolfiveyearsaftercoronarybypassgrafting